ASCO Survey on COVID-19 in Oncology (ASCO) Registry

计划入组 7,000 人 · 首次发布于 2020 年 12 月 9 日

Adaptive Radiotherapy for Genitourinary Cancers

计划入组 60 人 · 首次发布于 2026 年 1 月 7 日

Genitourinary Tumors With Sacituzumab Tirumotecan

计划入组 100 人 · 首次发布于 2026 年 7 月 21 日

Drotaverine

C₂₄H₃₁NO₄ · Rx

ASCJ-Q

AFCo-1

THE UNIVERSITY OF SYDNEY

Australia

NHS FIFE

United Kingdom

SHANGHAI MODERN PHARMACEUTICAL CO.,LTD.

China

Caris Life Sciences to Present Novel Cancer Research at 2025 ASCO GU Symposium

Lenvatinib-Pembrolizumab Combination Shows Promise as First-Line Treatment for Advanced Renal Cell Carcinoma

Lantheus to Present New PYLARIFY Data for Early Prostate Cancer Detection at ASCO GU 2025